COMP and breast cancer: ER positive tumors were associated (p = 0.019) with higher average serum COMP levels (n = 80, 12.36 U/L) compared with ER negative tumors (n = 96, 9.69 U/L), in accordance with previous observations in 2 breast cancer patients cohorts (1).